155 related articles for article (PubMed ID: 27089314)
1. In Vitro Activity of Selected West African Medicinal Plants against Mycobacterium ulcerans Disease.
Tsouh Fokou PV; Kissi-Twum AA; Yeboah-Manu D; Appiah-Opong R; Addo P; Tchokouaha Yamthe LR; Ngoutane Mfopa A; Fekam Boyom F; Nyarko AK
Molecules; 2016 Apr; 21(4):445. PubMed ID: 27089314
[TBL] [Abstract][Full Text] [Related]
2. Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.
Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Addo P; Asante IK; Boyom FF
J Ethnopharmacol; 2015 Aug; 172():297-311. PubMed ID: 26099634
[TBL] [Abstract][Full Text] [Related]
3.
Amponsah IK; Atchoglo PK; Ackah RY; Tsouh Fokou PV; Aboagye SY; Yeboah-Manu D; Appiah-Opong R; Mensah AY
Int J Mycobacteriol; 2021; 10(1):60-65. PubMed ID: 33707373
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial ingredients from plants used in traditional medicine to treat Buruli ulcer.
Tsouh Fokou PV; Kissi-Twum AA; Yeboah-Manu D; Appiah-Opong R; Addo P; Yamthe LR; Mfopa AN; Boyom FF; Nyarko AK
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S204-S205. PubMed ID: 28043556
[TBL] [Abstract][Full Text] [Related]
5. Beninese Medicinal Plants as a Source of Antimycobacterial Agents: Bioguided Fractionation and In Vitro Activity of Alkaloids Isolated from Holarrhena floribunda Used in Traditional Treatment of Buruli Ulcer.
Yemoa A; Gbenou J; Affolabi D; Moudachirou M; Bigot A; Anagonou S; Portaels F; Martin A; Quetin-Leclercq J
Biomed Res Int; 2015; 2015():835767. PubMed ID: 26180813
[TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial activity of medicinal plants against the causative agent of buruli ulcer: Mycobacterium ulcerans.
Keumoe R; Nguembou MS; Tsouh FP; Donkeng DV; Dize D; Tchokouaha YL; Jiatsa MC; Youmsi FR; Ngameni B; Fekam BF
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S105. PubMed ID: 28043490
[TBL] [Abstract][Full Text] [Related]
7. Buruli ulcer: a review of in vitro tests to screen natural products for activity against Mycobacterium ulcerans.
Yemoa A; Gbenou J; Affolabi D; Moudachirou M; Bigot A; Anagonou S; Portaels F; Quetin-Leclercq J; Martin A
Planta Med; 2011 Apr; 77(6):641-6. PubMed ID: 21240839
[TBL] [Abstract][Full Text] [Related]
8. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model.
Liu Y; Gao Y; Liu J; Tan Y; Liu Z; Chhotaray C; Jiang H; Lu Z; Chiwala G; Wang S; Makafe G; Islam MM; Hameed HMA; Cai X; Wang C; Li X; Tan S; Zhang T
Nat Commun; 2019 Jan; 10(1):524. PubMed ID: 30705268
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial potency and cytotoxicity study of three medicinal plants.
Tsouh Fokou PV; Appiah-Opong R; Yeboah-Manu D; Kissi-Twum AA; Yamthe LR; Mokale Kognou AL; Addo P; Boyom FF; Nyarko AK
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S206-S207. PubMed ID: 28043557
[TBL] [Abstract][Full Text] [Related]
10. Update on Medicinal Plants with Potency on Mycobacterium ulcerans.
Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Ofosuhene M; Boyom FF
Biomed Res Int; 2015; 2015():917086. PubMed ID: 26779539
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of avermectins against Mycobacterium ulcerans.
Omansen TF; Porter JL; Johnson PD; van der Werf TS; Stienstra Y; Stinear TP
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003549. PubMed ID: 25742173
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G
Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
[TBL] [Abstract][Full Text] [Related]
13. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic management of
Van Der Werf TS; Barogui YT; Converse PJ; Phillips RO; Stienstra Y
Expert Rev Clin Pharmacol; 2020 Apr; 13(4):391-401. PubMed ID: 32310683
[TBL] [Abstract][Full Text] [Related]
15. Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-
Kwofie SK; Enninful KS; Yussif JA; Asante LA; Adjei M; Kan-Dapaah K; Tiburu EK; Mensah WA; Miller WA; Mosi L; Wilson MD
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234337
[TBL] [Abstract][Full Text] [Related]
16. Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.
Guarner J
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343539
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique.
Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ
J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059
[TBL] [Abstract][Full Text] [Related]
18. Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment.
Scherr N; Pluschke G; Thompson CJ; Ramón-García S
PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003996. PubMed ID: 26270480
[TBL] [Abstract][Full Text] [Related]
19. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
Silva MT; Portaels F; Pedrosa J
Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Mycobacterium ulcerans cytochrome bc
Scherr N; Bieri R; Thomas SS; Chauffour A; Kalia NP; Schneide P; Ruf MT; Lamelas A; Manimekalai MSS; Grüber G; Ishii N; Suzuki K; Tanner M; Moraski GC; Miller MJ; Witschel M; Jarlier V; Pluschke G; Pethe K
Nat Commun; 2018 Dec; 9(1):5370. PubMed ID: 30560872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
